This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
The Dutram Report: Archive
How to Invest in 50 Undervalued Brands with One ETF
by Eric Dutram
Can focusing on companies with strong brands lead to solid stock performance? Listen to this podcast to find out more about the concept and why brand value is often an overlooked metric for investors.
AAPLPositive Net Change ACSIPositive Net Change AXPPositive Net Change BLMNNegative Net Change
Snapchat Won't Be in the S&P 500, Should Investors Care?
by Eric Dutram
SNAP stock is going to be excluded from major market indexes, this podcast tells you why this is important to all investors going forward.
FBNo Net Change GOOGLPositive Net Change SNAPNegative Net Change BRK.BNegative Net Change
Shareholder Yield: A Better Approach for Dividend Investors?
by Eric Dutram
How investors can go beyond dividends and consider the entire shareholder yield picture to find some of the best stocks in the market today.
LUVPositive Net Change NOCPositive Net Change EYLDNegative Net Change GDOTPositive Net Change
How to Invest in the Internet of Things and the FinTech Revolution
by Eric Dutram
Two important areas of the latest tech revolution in the worlds of the Internet of Things and FinTech. This podcast takes a look at both areas and what you need to know before investing in either one of them. So, check out this edition of the Dutram Report for more info!
AMZNNegative Net Change PYPLPositive Net Change SWKSNegative Net Change INTUNegative Net Change
How to Build a Portfolio: Have Investors Been Doing It Wrong?
by Eric Dutram
Are investors forgetting about a key factor when constructing their portfolios? This podcast takes a look at this topic and a potentially better way for investors to allocate their assets.
TLTPositive Net Change SPYNegative Net Change EMBPositive Net Change HEDJNegative Net Change
Can These ETFs Manage Risk and Avoid Black Swans?
by Eric Dutram
How can investors manage their risk with ETFs? We take a look at an approach that allocates between offense and defense in this podcast!
SPYNegative Net Change VXXPositive Net Change EFAPositive Net Change
How Kite Pharma Is Revolutionizing the Fight Against Cancer
by Eric Dutram
Immunotherapy is a hot corner of the biotech world. Learn how companies in this sector fight cancer in this podcast which features Dr. David Chang, the Chief Medical Officer of Kite Pharma. Do not miss it!
IBBNegative Net Change XBINegative Net Change KITENegative Net Change
Stocks to Fight Cancer: Why Immunotherapy Is a Gamechanger
by Eric Dutram
This podcast takes a closer look at the world of cancer research, and in particular, that of immunotherapy. I have guest Brad Loncar on to discuss this market and a few promising candidates to watch in this area, check it out for more info on this interesting biotech segment!
PFEPositive Net Change MRKPositive Net Change INCYNegative Net Change
What Is a 'Short Squeeze' and Can Investors Profit from the Strategy?
by Eric Dutram
Sometimes, short sellers get a little too greedy and bet against promising stocks. There is a fund that looks to find these securities, and ride a panic wave of short covering, to profits. Find out more about this approach in this week's podcast.
CHGGPositive Net Change SIRIPositive Net Change HDGENegative Net Change IRDMNegative Net Change
Guide to Investing in Robotics Stocks: What's the Future in Automation?
by Eric Dutram
The rise of the machines could be creating a big opportunity for investors. This podcast takes a look at the robotics and automation market from an investing perspective, highlighting what you need to know before jumping into this space.
QCOMNegative Net Change NOCPositive Net Change AMBANegative Net Change ROBONegative Net Change